166 related articles for article (PubMed ID: 15009102)
1. Analysis of APAF-1 expression in human cutaneous melanoma progression.
Baldi A; Santini D; Russo P; Catricalà C; Amantea A; Picardo M; Tatangelo F; Botti G; Dragonetti E; Murace R; Tonini G; Natali PG; Baldi F; Paggi MG
Exp Dermatol; 2004 Feb; 13(2):93-7. PubMed ID: 15009102
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma.
Soengas MS; Capodieci P; Polsky D; Mora J; Esteller M; Opitz-Araya X; McCombie R; Herman JG; Gerald WL; Lazebnik YA; Cordón-Cardó C; Lowe SW
Nature; 2001 Jan; 409(6817):207-11. PubMed ID: 11196646
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of Apaf-1 with progression of melanoma.
Mustika R; Budiyanto A; Nishigori C; Ichihashi M; Ueda M
Pigment Cell Res; 2005 Feb; 18(1):59-62. PubMed ID: 15649154
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis protease activator protein-1 expression is dispensable for response of human melanoma cells to distinct proapoptotic agents.
Zanon M; Piris A; Bersani I; Vegetti C; Molla A; Scarito A; Anichini A
Cancer Res; 2004 Oct; 64(20):7386-94. PubMed ID: 15492260
[TBL] [Abstract][Full Text] [Related]
5. Patterns of melastatin mRNA expression in melanocytic tumors.
Deeds J; Cronin F; Duncan LM
Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
[TBL] [Abstract][Full Text] [Related]
6. Apaf-1 expression in human cutaneous melanoma progression and in pigmented nevi.
Niedojadło K; Łabedzka K; Łada E; Milewska A; Chwirot BW
Pigment Cell Res; 2006 Feb; 19(1):43-50. PubMed ID: 16420245
[TBL] [Abstract][Full Text] [Related]
7. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M
J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845
[TBL] [Abstract][Full Text] [Related]
8. APAF-1 signaling in human melanoma.
Anichini A; Mortarini R; Sensi M; Zanon M
Cancer Lett; 2006 Jul; 238(2):168-79. PubMed ID: 16095810
[TBL] [Abstract][Full Text] [Related]
9. Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases.
Becker B; Multhoff G; Farkas B; Wild PJ; Landthaler M; Stolz W; Vogt T
Exp Dermatol; 2004 Jan; 13(1):27-32. PubMed ID: 15009113
[TBL] [Abstract][Full Text] [Related]
10. PUMA expression is significantly reduced in human cutaneous melanomas.
Karst AM; Dai DL; Martinka M; Li G
Oncogene; 2005 Feb; 24(6):1111-6. PubMed ID: 15690057
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of nuclear ING3 expression in human cutaneous melanoma.
Wang Y; Dai DL; Martinka M; Li G
Clin Cancer Res; 2007 Jul; 13(14):4111-6. PubMed ID: 17634537
[TBL] [Abstract][Full Text] [Related]
12. Loss of EphB6 expression in metastatic melanoma.
Hafner C; Bataille F; Meyer S; Becker B; Roesch A; Landthaler M; Vogt T
Int J Oncol; 2003 Dec; 23(6):1553-9. PubMed ID: 14612926
[TBL] [Abstract][Full Text] [Related]
13. Expression of thyrotropin-releasing hormone by human melanoma and nevi.
Ellerhorst JA; Naderi AA; Johnson MK; Pelletier P; Prieto VG; Diwan AH; Johnson MM; Gunn DC; Yekell S; Grimm EA
Clin Cancer Res; 2004 Aug; 10(16):5531-6. PubMed ID: 15328193
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
15. Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases.
Kraehn GM; Utikal J; Udart M; Greulich KM; Bezold G; Kaskel P; Leiter U; Peter RU
Br J Cancer; 2001 Jan; 84(1):72-9. PubMed ID: 11139316
[TBL] [Abstract][Full Text] [Related]
16. Identification of the human PHLDA1/TDAG51 gene: down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation.
Neef R; Kuske MA; Pröls E; Johnson JP
Cancer Res; 2002 Oct; 62(20):5920-9. PubMed ID: 12384558
[TBL] [Abstract][Full Text] [Related]
17. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
18. Detection of mitochondria-mediated apoptosis signaling molecules in ameloblastomas.
Kumamoto H; Ooya K
J Oral Pathol Med; 2005 Oct; 34(9):565-72. PubMed ID: 16138896
[TBL] [Abstract][Full Text] [Related]
19. SOX10 expression in superficial spreading and nodular malignant melanomas.
Agnarsdóttir M; Sooman L; Bolander A; Strömberg S; Rexhepaj E; Bergqvist M; Ponten F; Gallagher W; Lennartsson J; Ekman S; Uhlen M; Hedstrand H
Melanoma Res; 2010 Dec; 20(6):468-78. PubMed ID: 20890226
[TBL] [Abstract][Full Text] [Related]
20. Reduced Apaf-1 expression in human cutaneous melanomas.
Dai DL; Martinka M; Bush JA; Li G
Br J Cancer; 2004 Sep; 91(6):1089-95. PubMed ID: 15305193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
